Justification for the lack of ISR data [Bioanalytics]

posted by Dr Andrew Leary – Ireland, 2013-03-18 10:52 (4846 d 11:02 ago) – Posting: # 10217
Views: 5,561

Dear All

I expect that many of you will have come across regulators who apply current bioanalytical guidelines to studies which were completed prior to 2011, without ISR.

The PKWP Q&A document from 10 DEC 2012 suggests that scientific justification for the lack of ISR might include taking into consideration "the width of the 90% confidence interval and the ratio to possibly justify that a false positive outcome due to ISR problems has a low probability".

Any ideas as to exactly how this might be achieved? :confused:

KR

Andrew Leary

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
134 visitors (0 registered, 134 guests [including 30 identified bots]).
Forum time: 22:55 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5